spesolimab - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Sort by: Updated date | Shortage status | Trade name

Product details	Supply Impact Dates	Further Details
SPEVIGO spesolimab (rch) 450 mg in 7.5 mL concentrated solution for infusion vial AUST R: 388597 Active ingredients: spesolimab Dosage form: Injection, intravenous infusion Sponsor: LEO Pharma Pty Ltd Phone: 1800 991 778	From 01 Oct 2026 to 01 Sep 2027	Shortage status: Anticipated Availability: Available Reason: Commercial Changes / Commercial viability Management action: Patients are advised to consult their healthcare professional to discuss alternative treatment options. Alternative unapproved products may be available under the Special Access Scheme (SAS). For further information about the SAS please see: https://www.tga.gov.au/form/special-access-scheme

Product details

Supply Impact Dates

Further Details

SPEVIGO spesolimab (rch) 450 mg in 7.5 mL concentrated solution for infusion vial
AUST R: 388597
Active ingredients:
spesolimab

Dosage form:
Injection, intravenous infusion

Sponsor:
LEO Pharma Pty Ltd

Phone:
1800 991 778

From
01 Oct 2026
to
01 Sep 2027

Shortage status:
Anticipated

Availability:
Available

Reason:
Commercial Changes / Commercial viability

Management action:
Patients are advised to consult their healthcare professional to discuss alternative treatment options. Alternative unapproved products may be available under the Special Access Scheme (SAS). For further information about the SAS please see: https://www.tga.gov.au/form/special-access-scheme